Lv11
2 积分 2020-06-09 加入
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
2小时前
待确认
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
4小时前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
5小时前
已完结
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
1天前
已完结
Efficacy and safety of KN046, a novel bispecific antibody against PD-L1 and CTLA-4, in patients with non-small cell lung cancer who failed platinum-based chemotherapy: a phase II study
2天前
已完结
Envafolimab: First Approval
2天前
已完结
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
21天前
已完结
ACSL family: The regulatory mechanisms and therapeutic implications in cancer
1个月前
已完结
A systematic review of the effect of semaglutide on lean mass: insights from clinical trials
2个月前
已完结
皖公网安备34019202002308
